AwardTape · Defense awards · Wells Pharma of Houston LLC
Wells Pharma of Houston LLC: $167K in DoD and DHS awards
Wells Pharma of Houston LLC holds 2 DoD and DHS prime awards with $167K obligated Oct 26, 2023 to Mar 27, 2025. Largest category: Drugs and biologicals at $167K; largest buyer: Department of the Army at $167K.
| Obligated FY2024+ | $167K |
|---|---|
| Awards | 2 |
| FY2024 | $151K |
| FY2025 | $15K |
| FY2026 to date | $0 |
| Lifetime obligated on these awards | $409K |
| First and latest action | Oct 26, 2023 · Mar 27, 2025 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Drugs and biologicals | $167K | 2 awards | 100% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Department of the Army | $167K | 1 awards | 100% |
| 2 | Defense Health Agency | $0 | 1 awards | 0.0% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| W81K0022P0048 purchase order | $167K | Norepinephrine | Army | Drugs and biologicals | Mar 27, 2025 DoD 90d |
| HT940823A0004 blanket purchase agreement | $0 | Prefilled syringes, naval hospital pensacola, fl | Defense Health Agency | Drugs and biologicals | Jan 8, 2024 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial